Home LiteratureArticle Details
PMID: 7592183 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Antimicrobial susceptibility of penicillin-sensitive and penicillin-resistant meningococci.

The Journal of antimicrobial chemotherapy ·Vol. 35 ·No. 5 ·1995-05-00 ·Pages 687-90

Abadi FJ, Yakubu DE, Pennington TH

Abstract

Ceftriaxone showed high in-vitro activity against 119 penicillin-sensitive, penicillin-resistant and rifampicin-resistant UK isolates of meningococci. Unlike ciprofloxacin and minocycline, ceftriaxone is suitable for use in young children or in pregnancy and should be considered for therapy or prophylaxis in an outbreak of meningococcal disease. The E test gave results comparable to those given by broth microdilution method in the determination of meningococcal susceptibility to antimicrobials. It is convenient for use in small laboratories and can be used to determine antimicrobial subgroups of meningococci.

MeSH Terms
Anti-Bacterial Agents/pharmacology Ceftriaxone/pharmacology Humans Microbial Sensitivity Tests Neisseria meningitidis/drug effects Penicillin G/pharmacology Penicillin Resistance Rifampin/pharmacology
Chemicals
Anti-Bacterial Agents Ceftriaxone Penicillin G Rifampin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Abadi F J
Department of Medical Microbiology, University of Aberdeen Medical School, Foresterhill, UK.
Yakubu D E
Pennington T H
Article Info
Journal
The Journal of antimicrobial chemotherapy
Abbr.
J Antimicrob Chemother
ISSN
0305-7453
Published
1995-05-00
Pages
687-90
Language
English
Region
England
NLM ID
7513617
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]